# OnCo record ifinatamab-deruxtecan (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ifinatamab-deruxtecan/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ifinatamab-deruxtecan" ;
  schema:name "Ifinatamab deruxtecan"@en ;
  schema:description "Ifinatamab deruxtecan is a B7-H3 ADC showing some of the best response rates ever seen in relapsed small-cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/ifinatamab-deruxtecan/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=I-DXd> ;
  onco:status "phase-3" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/extensive-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/b7h3/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/>, <https://onco.cc/companies/merck/> ;
  onco:terms <https://onco.cc/terms/ggfg/> ;
  onco:trials <https://onco.cc/trials/nct06925737/>, <https://onco.cc/trials/nct06780137/>, <https://onco.cc/trials/nct05280470/>, <https://onco.cc/trials/nct04471727/>, <https://onco.cc/trials/nct06362252/>, <https://onco.cc/trials/nct07227597/>, <https://onco.cc/trials/nct04145622/>, <https://onco.cc/trials/nct06330064/>, <https://onco.cc/trials/nct07630974/>, <https://onco.cc/trials/nct06863272/>, <https://onco.cc/trials/nct06644781/>, <https://onco.cc/trials/nct06780085/> .